‹ back to list

Acarix A/S

E-health
Service&Operational
Rehab
Healthcare Buildings
Medical Devices
Pharmaceuticals

What we offer

Acarix A/S was established in 2009 as a spinout from Coloplast A/S. Since 2010 key investors SEED Capital Denmark and Sunstone Life Science Ventures have financed the company and supported it towards market introduction.
Acarix is a medical device company specializing in non-invasive, non-radiation acoustic detection of Coronary Artery Disease (CAD).

Products and solutions

Acarix CADScor®System

The CADScor®System combines acoustic detection of turbulent arterial flow and myocardial movement with advanced algorithms in a handheld device to provide a patient specific CAD-score in less than 10 minutes. The CADScor®System meets a major unmet need as Coronary Artery Disease (CAD) affects more than 120 million people worldwide but the current diagnostic pathway, which can rapidly escalate to expensive and potentially harmful imaging and invasive coronary angiography, is inefficient. Learn more ›

Case stories

billede1.tif

Acarix CADScor®System

A recent Danish study showed that more than 90% of patients presenting Coronary Artery Disease (CAD) symptoms to their general practitioner do not have CAD. With the Acarix CADScor®System we have an easy to use non-invasive tool able to rule out CAD with 96% negative predictive value. This also translates into a potential to reduce onward patient referrals by ~50%. – a win-win for patients, payers and physicians.

Contact

Søren Rysholt Christiansen
dksrc@acarix.com

Acarix A/S

Diplomvej 376
2800 Kongens Lyngby
www.acarix.com

Find us here:

Others also viewed
A-Data A/S See profile ›
Rightimage2
建立商业合作-计划考察

我们可为您安排您在丹麦的 考察行程 。

了解更多
快讯 - 最新资讯
Newsletter
获取有关新闻,活动和公司资料的更新